150 related articles for article (PubMed ID: 31161818)
21. MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7.
Gong J; Cui Z; Li L; Ma Q; Wang Q; Gao Y; Sun H
Tumour Biol; 2015 Sep; 36(10):7831-40. PubMed ID: 25944166
[TBL] [Abstract][Full Text] [Related]
22. MiR-182 promotes glioma progression by targeting FBXW7.
Liu S; Liu H; Deng M; Wang H
J Neurol Sci; 2020 Apr; 411():116689. PubMed ID: 32032908
[TBL] [Abstract][Full Text] [Related]
23. Mixed large cell neuroendocrine carcinoma and squamous cell carcinoma of the colon: detailed molecular characterisation of two cases indicates a distinct colorectal cancer entity.
Woischke C; Jung P; Jung A; Kumbrink J; Eisenlohr S; Auernhammer CJ; Vieth M; Kirchner T; Neumann J
J Pathol Clin Res; 2021 Jan; 7(1):75-85. PubMed ID: 33197299
[TBL] [Abstract][Full Text] [Related]
24. FBXW7 expression affects the response to chemoradiotherapy and overall survival among patients with oral squamous cell carcinoma: A single-center retrospective study.
Arita H; Nagata M; Yoshida R; Matsuoka Y; Hirosue A; Kawahara K; Sakata J; Nakashima H; Kojima T; Toya R; Murakami R; Hiraki A; Shinohara M; Nakayama H
Tumour Biol; 2017 Oct; 39(10):1010428317731771. PubMed ID: 29072128
[TBL] [Abstract][Full Text] [Related]
25. TINCR suppresses proliferation and invasion through regulating miR-544a/FBXW7 axis in lung cancer.
Liu X; Ma J; Xu F; Li L
Biomed Pharmacother; 2018 Mar; 99():9-17. PubMed ID: 29324317
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive Study of Human FBXW7 Deleterious nsSNP's Functional Inference and Susceptibility to Gynaecological Cancer.
Vasuki KA; Christy HJ
Appl Biochem Biotechnol; 2022 Jan; 194(1):407-433. PubMed ID: 34817806
[TBL] [Abstract][Full Text] [Related]
27. [Mutations of FBXW7 in Adult T-Cell Acute Lymphocytic Leukemia].
Guo X; Zhang R; Ge Z; Xu JY; Li M; Qiao C; Qiu HR; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):612-8. PubMed ID: 26117003
[TBL] [Abstract][Full Text] [Related]
28. SCF
O'Brien S; Kelso S; Steinhart Z; Orlicky S; Mis M; Kim Y; Lin S; Sicheri F; Angers S
EMBO Rep; 2022 Dec; 23(12):e55044. PubMed ID: 36278408
[TBL] [Abstract][Full Text] [Related]
29. Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses.
Kuhn E; Wu RC; Guan B; Wu G; Zhang J; Wang Y; Song L; Yuan X; Wei L; Roden RB; Kuo KT; Nakayama K; Clarke B; Shaw P; Olvera N; Kurman RJ; Levine DA; Wang TL; Shih IeM
J Natl Cancer Inst; 2012 Oct; 104(19):1503-13. PubMed ID: 22923510
[TBL] [Abstract][Full Text] [Related]
30. FBXW7: a critical tumor suppressor of human cancers.
Yeh CH; Bellon M; Nicot C
Mol Cancer; 2018 Aug; 17(1):115. PubMed ID: 30086763
[TBL] [Abstract][Full Text] [Related]
31. FBXW7 is involved in the acquisition of the malignant phenotype in epithelial ovarian tumors.
Kitade S; Onoyama I; Kobayashi H; Yagi H; Yoshida S; Kato M; Tsunematsu R; Asanoma K; Sonoda K; Wake N; Hata K; Nakayama KI; Kato K
Cancer Sci; 2016 Oct; 107(10):1399-1405. PubMed ID: 27486687
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-25 Exerts an Oncogenic Function by Regulating the Ubiquitin Ligase Fbxw7 in Hepatocellular Carcinoma.
El-Mezayen H; Yamamura K; Yusa T; Nakao Y; Uemura N; Kitamura F; Itoyama R; Yamao T; Higashi T; Hayashi H; Imai K; Chikamoto A; Yamashita YI; Baba H
Ann Surg Oncol; 2021 Nov; 28(12):7973-7982. PubMed ID: 33886022
[TBL] [Abstract][Full Text] [Related]
33. Recent insight into the role of FBXW7 as a tumor suppressor.
Yumimoto K; Nakayama KI
Semin Cancer Biol; 2020 Dec; 67(Pt 2):1-15. PubMed ID: 32113998
[TBL] [Abstract][Full Text] [Related]
34. Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway.
Wang X; Zhang J; Zhou L; Sun W; Zheng ZG; Lu P; Gao Y; Yang XS; Zhang ZC; Tao KS; Dou KF
Int J Oncol; 2015 Jul; 47(1):231-43. PubMed ID: 25955618
[TBL] [Abstract][Full Text] [Related]
35. The landscape of somatic mutations in Indonesian cervical cancer is predominated by the PI3K pathway.
Spaans VM; Nyoman Bayu Mahendra I; Purwoto G; Trietsch MD; Osse M; Ter Haar N; Peters AAW; Fleuren GJ; Jordanova ES
Gynecol Oncol; 2018 Jan; 148(1):189-196. PubMed ID: 29113722
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathologic characteristics of FBXW7-mutated colorectal adenocarcinoma and association with aberrant beta-catenin localization.
Escobar D; Bushara O; Sun L; Liao J; Yang GY
Hum Pathol; 2022 Jan; 119():51-58. PubMed ID: 34717891
[TBL] [Abstract][Full Text] [Related]
37. Loss of FBXW7 and accumulation of MCL1 and PLK1 promote paclitaxel resistance in breast cancer.
Gasca J; Flores ML; Giráldez S; Ruiz-Borrego M; Tortolero M; Romero F; Japón MA; Sáez C
Oncotarget; 2016 Aug; 7(33):52751-52765. PubMed ID: 27409838
[TBL] [Abstract][Full Text] [Related]
38. FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy.
Xiao Y; Yin C; Wang Y; Lv H; Wang W; Huang Y; Perez-Losada J; Snijders AM; Mao JH; Zhang P
Mol Oncol; 2018 Jun; 12(6):883-895. PubMed ID: 29633504
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of microRNA-223 regulates the ubiquitin ligase FBXW7 in oesophageal squamous cell carcinoma.
Kurashige J; Watanabe M; Iwatsuki M; Kinoshita K; Saito S; Hiyoshi Y; Kamohara H; Baba Y; Mimori K; Baba H
Br J Cancer; 2012 Jan; 106(1):182-8. PubMed ID: 22108521
[TBL] [Abstract][Full Text] [Related]
40. Proteomic profiling of FBXW7-mutant serous endometrial cancer cells reveals upregulation of PADI2, a potential therapeutic target.
Urick ME; Bell DW
Cancer Med; 2020 Jun; 9(11):3863-3874. PubMed ID: 32248654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
